Oversight and Investigations Subcommittee to Hold Hearing on the Rising Cost of Insulin
Washington, D.C. – Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) and Oversight & Investigations Subcommittee Chair Diana DeGette (D-CO) announced today that the Oversight and Investigations Subcommittee will hold a hearing on Tuesday, April 2, at 10:30 am in 2322 of the Rayburn House Office Building. The hearing is entitled, “Priced Out of a Lifesaving Drug: The Human Impact of Rising Insulin Costs.” This will be the first of two hearings the Subcommittee will hold on the rising cost of insulin over the next month.
“The skyrocketing cost of insulin is a direct threat to the health and financial wellbeing of the millions of Americans living with diabetes,” Pallone and DeGette said. “Next week’s hearing will be an important opportunity to hear directly from stakeholders including patient advocates on the challenges of insulin affordability and the financial and health consequences on patients’ lives.”
Information for this hearing, including witness testimony and a link to the live webcast, will be posted HERE as they become available.